CannabisNewsBreaks

TuesdayOct 25, 2022 10:50 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Webcast to Discuss M&A, International Markets

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has scheduled an analyst call for Oct. 26, 2022, at 2 p.m. EST. According to the announcement, the call will focus on the company’s recent M&A activity as well as growth opportunities in the international space. Leadership from Flora Growth, along with Franchise Global Health Inc., will be on the call to discuss the recent definitive agreement that two companies have signed regarding acquisition; discussion will also center on global opportunities within the cannabis industry. Through its subsidiaries, Franchise Global Health is a multinational…

Continue Reading

MondayOct 24, 2022 10:29 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Acquisition Agreement with German-Based Pharmaceutical, Medical Cannabis Distributor

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a definitive agreement with Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry. The agreement outlines Flora Growth’s plans to acquire 100% of Franchise Global Health, which has principal operations in Germany, in an all-stock transaction. According to the agreement, the acquisition gives FLGC a foothold in German’s medical cannabis space because FGH’s German businesses service an estimated 1,200 pharmacies in the country; FGH also provides noncannabis medical products to 28 additional countries. In the first…

Continue Reading

FridayOct 21, 2022 3:21 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Holds Potential to Represent Multiple Commercial Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a drug delivery platform innovator, last year announced a review of its successful 2021 antiviral drug program. “Lexaria specifically probed the bioavailability of five DehydraTECH(TM)-processed antiviral drugs for SARS-CoV-2, HIV/AIDS and other infectious diseases from three drug classes, evidencing significant gains with up to a three-fold increase in oral drug delivery into the bloodstream. The demonstrated improvements in absorption, Lexaria believed, could have significant commercial potential considering that many antiviral drugs typically show low oral bioavailability in their available form because of significant liver biotransformation and/or poor intestinal uptake,” reads a recent article. “Lexaria’s vision…

Continue Reading

WednesdayOct 19, 2022 2:52 pm

CannabisNewsBreaks – REZYFi Inc.’s Diversified Approach Positions It to Capitalize on Growth Across Multiple Verticals

REZYFi, a mortgage lender company servicing the needs of both traditional and non-traditional consumers and businesses, is positioned to be one of the first cannabis mortgage bankers in the United States. In this industry, many traditional lenders are reticent to serve the state-licensed cannabis sector. “REZYFi operates through two wholly owned subsidiaries: REZYFi Lending and ResMac Inc. Leveraging a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA and VA loans, reverse mortgages, jumbo loans, and adjustable-rate mortgages, REZYFi Lending expects increased funding in marketing and loan agents to drive origination growth over the next two…

Continue Reading

WednesdayOct 19, 2022 2:17 pm

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Anticipates Leadership Position in Alternative Cannabinoid Market Segment

Flora Growth Corp. (NASDAQ: FLGC), a global cannabis cultivator, product manufacturer and distributor, is measuring its success in rapidly rising revenues brought on by strategic acquisitions and the expanding international movement of its brands. “The company recently reported a 604% increase YoY in its H1 revenues to about $15 million, which was also a 117% increase over the previous half-year financial report, and is anticipating new momentum from the recent acquisition of the No Cap Hemp Co. brand by Flora’s wholly owned subsidiary Just Brands LLC. The No Cap acquisition is expected to add some 75 SKUs to Flora’s product…

Continue Reading

WednesdayOct 19, 2022 12:47 pm

CannabisNewsBreaks – AmeriCann (ACAN) Announces Record Revenue, Strong Top-Line Growth

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, today provided financial and operational updates for its Massachusetts cannabis cultivation, product manufacturing and distribution campus. According to the update, the company achieved a significant increase in year-over-year revenue, increasing over 44% for the year ending September 2022 relative to the year ended Sept. 30, 2021, an increase of over $900,000. The company attributed the increase in financial performance to greater revenue received from products produced and manufactured at building 1, AmeriCann’s initial building at its Massachusetts Cannabis Center development in Freetown, Massachusetts. “We’re pleased…

Continue Reading

WednesdayOct 19, 2022 12:41 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) CEFs Hold Potential to Transform the Way Food is Grown, Distributed

Advanced Container Technologies (OTC: ACTX) has announced that GrowPods – the company’s unique Controlled Environment Farms (“CEFs”), have the potential to transform the agriculture industry. Among the many benefits CEFs provide are year-round growing cycles, which are not dependent on weather, climate or quality of land, and can provide reliable and consistent crop production. “Controlled Environment Farming isn’t perfect, but it has the potential to transform the agriculture sector and improve the way food is grown and distributed in America,” said Doug Heldoorn, CEO of ACTX. “From improving the quality of our food, to reducing our dependence on corporate owned…

Continue Reading

ThursdayOct 13, 2022 2:52 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Pipeline Addressing Severe Unmet Patient Needs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a biotechnology company focusing its attention and resources on pursuing the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients, developed the patented DehydraTECH(TM) drug delivery technology. “The company has evidenced, through in-vivo, in-vitro and pre-clinical testing, that DehydraTECH delivers more APIs at a faster rate than controls, enabling more effective drug absorption. The testing has so far involved APIs such as cannabidiol (‘CBD’), PDE5 inhibitors, antiviral drugs, and nicotine, each at different stages of product development. This DehydraTECH pipeline, Lexaria says, is addressing severe unmet patient needs. Its DehydraTECH-CBD…

Continue Reading

ThursdayOct 13, 2022 1:38 pm

CannabisNewsBreaks – SHF Holdings Inc. (NASDAQ: SHFS) Continues Trading on the Nasdaq After Successful Business Combination

SHF Holdings (NASDAQ: SHFS), formerly known as Northern Lights Acquisition Corp. ("NLIT"), a special purpose acquisition company, recently completed its acquisition of SHF LLC, d/b/a Safe Harbor Financial, a leader in offering compliance services to financial institutions that serve the regulated cannabis industry. With the transaction now complete, the company has changed its name to “SHF Holdings Inc.,” with its Class A Common Stock and warrants continuing to trade on the Nasdaq Capital Market. “With its established leadership position in cannabis-related compliance services and continued growth in its financial institution clients, this is an exciting time for Safe Harbor to…

Continue Reading

ThursdayOct 13, 2022 1:23 pm

CannabisNewsBreaks – REZYFi Inc. Looking to Fill Financial Services Vacuum for Cannabis Industry

REZYFi is a real estate-oriented loan origination and servicing company serving the needs of both traditional and non-traditional consumers and businesses. “With top U.S. banks and payment companies adhering to federal law [which criminalizes the possession and use of cannabis], they have opted out of serving cannabis companies.’ This had long starved companies of the ability to transact electronically, take out loans and make deposits. However, the situation is changing for the better thanks to financial services companies like REZYFi that have emerged to cater to the cannabis industry,” reads a recent article, which contains excerpts from a Financial Times…

Continue Reading